Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock price
Equities
600329
CNE000001808
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.12 CNY | +0.86% | -2.33% | -16.43% |
Sales 2023 * | 8.55B 1.18B | Sales 2024 * | 9.64B 1.33B | Capitalization | 18.94B 2.62B |
---|---|---|---|---|---|
Net income 2023 * | 1.08B 150M | Net income 2024 * | 1.28B 177M | EV / Sales 2023 * | 2.22 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.97 x |
P/E ratio 2023 * |
20
x | P/E ratio 2024 * |
16.9
x | Employees | 4,913 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 31.62% |
1 day | +0.86% | ||
1 week | -2.33% | ||
Current month | -6.24% | ||
1 month | -3.93% | ||
3 months | -15.35% | ||
6 months | -22.81% | ||
Current year | -16.43% |
Managers | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
42 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 19-09-29 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 36 M€ | +4.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 28.12 | +0.86% | 4,356,323 |
24-03-27 | 27.88 | -1.10% | 5,963,674 |
24-03-26 | 28.19 | +0.64% | 3,515,663 |
24-03-25 | 28.01 | -0.28% | 4,657,842 |
24-03-22 | 28.09 | -2.43% | 5,966,078 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.43% | 2.62B | |
+23.32% | 5.42B | |
-12.48% | 4.67B | |
-6.70% | 3.27B | |
-2.41% | 2.54B | |
-7.97% | 1.68B | |
+24.37% | 1.66B | |
-8.02% | 1.62B | |
-4.40% | 1.58B | |
-8.51% | 1.42B |